CCNA1 and cancer: We observed a statistically significant correlation between cyclin A1 and VEGF in cancer specimens from the two patient cohorts (In the 94-patient cohort: r2=0.362, p<0.01; and in the 48-patient cohort: r2=0.288, p<0.01) (Table 2) (Figure 1B).